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A B S T R A C T
Background: Problem-solving therapy (PST) is one of the best examined types of psychotherapy for adult
depression. No recent meta-analysis has examined the effects of PST compared to control groups or to
other treatments. We wanted to verify whether PST is effective, whether effects are comparable to those
of other treatments, and whether we could identify the possible sources of high heterogeneity that was
found in earlier meta-analyses.
Methods: We conducted systematic searches in bibliographical databases, including PubMed, PsycInfo,
Embase and the Cochrane database of randomized trials.
Results: We included 30 randomized controlled trials on PST (with 3530 patients), in which PST was
compared to control conditions, with other therapies, and with pharmacotherapy. We could compare
these 30 trials on PST also with 259 trials on other psychotherapies for adult depression. The effect size of
PST versus control groups was g = 0.79 (0.57–1.01) with very high heterogeneity (I2 = 84; 95% CI: 77–88).
The effect size from the 9 studies with low risk of bias was g = 0.34 (95% CI: 0.22–0.46) with low
heterogeneity (I2 = 32; 95% CI: 0–68), which is comparable to the effects of other psychotherapies. PST
was a little more effective than other therapies in direct comparisons, but that may be explained by the
considerable number of studies with researcher allegiance towards PST. In meta-regression analyses of
all controlled studies, no significant difference between PST and other therapies was found.
Conclusion: PST is probably an effective treatment for depression, with effect sizes that are small, but
comparable to those found for other psychological treatments of depression.
C 2017 Elsevier Masson SAS. All rights reserved.1. Introduction
In the past decades dozens of psychological interventions for
the treatment of depression have been developed. However, only a
relatively small number of these treatments have been tested in
ten or more randomized trials. The therapies that have been well-
examined include cognitive behavior therapy [1,2], interpersonal
psychotherapy [3,4], behavioral activation [5,6], brief psychody-
namic therapy [7,8] and non-directive counseling [9]. When
considering the several hundreds of randomized controlled and
comparative trials that have examined psychotherapies for* Corresponding author at: Department of Clinical, Neuro and Developmental
Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit
Amsterdam, Van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands.
E-mail address: p.cuijpers@vu.nl (P. Cuijpers).
https://doi.org/10.1016/j.eurpsy.2017.11.006
0924-9338/C 2017 Elsevier Masson SAS. All rights reserved.depression, it has become clear that these therapies have modest
but clinically relevant effects [10]. Furthermore, this area of
research has shown that there are no major differences between
the effects of these treatments [11], that these treatments can be
delivered effectively in individual, group, guided self-help and
internet-delivered format [12–14], and that they are effective in
several different target groups, such as older adults [15,16],
children and adolescents [17], postpartum depression [18], college
students [19], and patients with comorbid general medical
disorders [20].
One of the interventions that has been tested as a treatment of
adult depression in a considerable number of randomized trials is
problem-solving therapy (PST). PST was developed in the 1970s as
one of the first treatments of depression [21], and was first tested
in the 1980s [22,23]. PST focuses on training in adaptive problem-
solving attitudes and skills and is aimed at reducing and
preventing psychopathology, and at enhancing positive well-being
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problems in daily life [24].
A decade ago we conducted a meta-analysis of trials testing the
effects of PST for adult depression [25]. The 13 trials that were
included in this meta-analysis pointed at a large effect of PST
versus control groups (d = 0.83), and some indications were found
that PST was more effective than other therapies, although that
was based on a small set of studies. Since this meta-analysis,
several other meta-analyses have been published [24,26,27]. How-
ever, the last comprehensive meta-analysis aimed at including all
trials on PST for depression was published in 2009 [24]. One meta-
analysis was published later [27], but that was only aimed at
studies among older adults. Because the number of trials on PST
has more than doubled since then, a new meta-analysis is much
needed. Furthermore, none of the comprehensive meta-analyses
examined the effects of the quality of the included trials on the
outcomes, nor was publication bias well examined.
Another reason why a new meta-analysis of PST is useful, is that
in our first meta-analysis a very high level of heterogeneity was
found, indicating that the effect sizes varied strongly across studies
[25]. It was not possible to identify possible causes of this
heterogeneity in subgroup and meta-regression analyses. It is
important, however, to know under which conditions PST has large
or small effects. Because the number of trials is now considerably
larger than 10 years ago, it may be possible to better identify
possible causes of heterogeneity.
We conducted a new meta-analysis of PST for adult depression.
We wanted to examine the overall effects of PST, the level of
heterogeneity and to conduct subgroup and meta-regression
analyses to examine potential causes of this heterogeneity.
Furthermore, we wanted to examine the relative effects of PST
compared with other psychological therapies. We wanted to
examine this from trials directly comparing PST with other
therapies, but also by comparing the effects found in trials
comparing PST with control groups, with the effects found for
other therapies that are compared with control groups.
2. Methods
2.1. Identification and selection of studies
We used an existing database of studies on the psychological
treatment of depression. This database has been described in detail
elsewhere [28], and has been used in a series of earlier published
meta-analyses [29]. For this database we searched four major
bibliographical databases (PubMed, PsycInfo, Embase and the
Cochrane Library) by combining terms (both index terms and text
words) indicative of depression and psychotherapies, with filters
for randomized controlled trials. The full search string for one
database (PubMed) is given in Appendix A in Supplementary
material. We also searched a number of bibliographical databases
to identify trials in non-Western countries [30], because the
number of trials on psychological treatments in these countries is
growing rapidly. Furthermore, we checked the references of earlier
meta-analyses on psychological treatments of depression. The
database is continuously updated and was developed through a
comprehensive literature search (from 1966 to January 1st, 2017).
All records were screened by two independent researchers and all
papers that could possibly meet inclusion criteria according to one
of the researchers were retrieved as full-text. The decision to
include or exclude a study in the database was also done by the two
independent researchers, and disagreements were solved through
discussion.
We included studies that were: (a) a randomized trial (b) in
which PST (c) for adult depression was (d) compared with a controlgroup (waiting list, care-as-usual, placebo, other inactive treat-
ment) or another treatment (psychological or pharmacological).
Depression could be established with a diagnostic interview or
with a score above a cut-off on a self-report measure. Co-morbid
mental or somatic disorders were not used as an exclusion
criterion. Studies on inpatients were excluded. We also excluded
maintenance studies, aimed at people who had already recovered
or partly recovered after an earlier treatment. We considered an
intervention to be PST when problem-solving was the core element
of the intervention that was meant to reduce depression. Other
techniques were allowed when they were aimed at supporting or
strengthening the problem-solving element. If other techniques
were clearly considered to be separate elements, we did not
consider it PST.
In addition to the main analyses in which we focused on the
studies on PST, we also wanted to compare the effects of PST with
the effects found for other psychological treatments of adult
depression. For this comparison we selected trials from our
database in which other types of psychotherapy for depression
were compared with a control condition, with the same in- and
exclusion criteria as for the studies on PST.
2.2. Quality assessment and data extraction
We assessed the validity of included studies using four criteria
of the ‘Risk of bias’ assessment tool, developed by the Cochrane
Collaboration [31]. This tool assesses possible sources of bias in
randomized trials, including the adequate generation of allocation
sequence; the concealment of allocation to conditions; the
prevention of knowledge of the allocated intervention (masking
of assessors); and dealing with incomplete outcome data (this was
assessed as positive when intention-to-treat analyses were
conducted, meaning that all randomized patients were included
in the analyses). Assessment of the validity of the included studies
was conducted by two independent researchers, and disagree-
ments were solved through discussion.
We also coded participant characteristics (depressive disorder
of scoring high on a self-rating scale; recruitment method; target
group); characteristics of the psychotherapies (treatment format;
number of sessions); and general characteristics of the studies
(type of control group; country where the study was conducted).
Treatment format was coded as individual, group or guided-self
help (including internet-based guided self-help).
We distinguished three types of PST [25]: (1) Extended PST,
which does not only focus on the problem-solving skills
themselves, but also on changing those attitudes or beliefs that
may inhibit or interfere with attempts to engage in the remaining
problem-solving tasks. It is typically conducted in a group format
of 10 or more sessions. We (arguably) considered an intervention
as extended PST when it had 10 sessions or more. (2) Brief PST,
which was originally developed for primary care (PST-PC), focuses
on the core elements of problem-solving and can be used by
trained nurses. We considered an intervention as brief PST when it
had 9 sessions or less. (3) Self-examination therapy (SET) is aimed
at determining the major goals in their life, investing energy only in
those problems that are related to what matters and learning to
accept those situations that cannot be changed. Problem-solving
skills are the core element of this approach. SET is typically used in
a guided-self-help format. We considered an intervention as SET
when it was based on self-examination therapy [32] and was
conducted in guided self-help format.
In the studies comparing PST with other therapies we also
examined researcher allegiance, using the methods we have
described before [9]. We coded that researcher allegiance was in
favor of PST (against the alternative therapy) if: (1) PST was the
only therapy mentioned in the title; (2) PST was explicitly
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tion section of the study; (3) the alternative therapy was explicitly
described as a control condition included to control for the non-
specific components of the comparison therapy; or (4) there was
an explicit hypothesis that PST was expected to be more effective
than the alternative therapy.
2.3. Outcome measures
For each comparison between PST (or another type of
psychotherapy) and a control condition, the effect size indicating
the difference between the two groups at post-test was calculated
(Hedges’ g). Effect sizes of 0.8 can be assumed to be large, while
effect sizes of 0.5 are moderate, and effect sizes of 0.2 are small
[33]. Effect sizes were calculated by subtracting (at post-test) the
average score of the psychotherapy group from the average score
of the control group, and dividing the result by the pooled standard
deviation. Because some studies had relatively small sample sizes
we corrected the effect size for small sample bias [34]. If means and
standard deviations were not reported, we used the procedures of
the Comprehensive Meta-Analysis software (see below) to
calculate the effect size using dichotomous outcomes; and if these
were not available either, we used other statistics (such a t-value or
p-value) to calculate the effect size.
In order to calculate effect sizes we used all measures
examining depressive symptoms (such as the Beck Depression
Inventory/BDI [35]; the BDI-II [36]; or the Hamilton Rating Scale
for Depression/HAMD-17 [37]).
2.4. Meta-analyses
To calculate pooled mean effect sizes, we used the computer
program Comprehensive Meta-Analysis (version 3.3070; CMA).
Because we expected considerable heterogeneity among the
studies, we employed a random effects pooling model in all
analyses.
Numbers-needed-to-be-treated (NNT) were calculated using
the formulae provided by Furukawa [38], in which the control
group’s event rate was set at a conservative 19% (based on the
pooled response rate of 50% reduction of symptoms across trials in
psychotherapy for depression) [39]. As a test of homogeneity of
effect sizes, we calculated the I2-statistic, which is an indicator of
heterogeneity in percentages. A value of 0% indicates no observed
heterogeneity, and larger values indicate increasing heterogeneity,
with 25% as low, 50% as moderate, and 75% as high heterogeneity
[33]. We calculated 95% confidence intervals around I2 [40], using
the non-central chi-squared-based approach within the heterogi
module for Stata [41]. We conducted sensitivity analyses excluding
potential outliers. These were defined as studies of which the 95%
CI of the effect size did not overlap with the 95% CI of the pooled
effect size.
We conducted subgroup analyses according to the mixed
effects model, in which studies within subgroups are pooled with
the random effects model, while tests for significant differences
between subgroups are conducted with the fixed effects model. For
continuous variables, we used meta-regression analyses to test
whether there was a significant relationship between the
continuous variable and effect size, as indicated by a Z-value
and an associated p-value. Multivariate meta-regression analyses,
with the effect size as the dependent variable, were conducted in
CMA.
We tested for publication bias by inspecting the funnel plot on
primary outcome measures and by Duval and Tweedie’s trim and
fill procedure [34], which yields an estimate of the effect size after
the publication bias has been taken into account (as implemented
in CMA). We also conducted Egger’s test of the intercept to quantifythe bias captured by the funnel plot and to test whether it was
significant.
3. Results
3.1. Selection and inclusion of studies
After examining a total of 18,500 abstracts (14,290 after
removal of duplicates), we retrieved 2,092 full-text papers for
further consideration. We excluded 1,827 of the retrieved papers.
The PRISMA flowchart describing the inclusion process, including
the reasons for exclusion, is presented in Fig. 1. A total of 30 studies
on PST met inclusion criteria for this meta-analysis (Table 1).
Another 264 studies (with 342 comparisons between a
treatment and a control group) on psychological treatments other
than PST were included (for the comparison of effect sizes of PST
with those of other psychological treatments). This makes a total of
290 studies that were included in the analyses.
3.2. Characteristics of included studies
Selected characteristics of the included studies are presented in
Table 1. In the 30 included studies on PST (with 12 comparisons
between PST and another therapy condition, and 27 comparisons
between PST and a control condition), a total of 3,530 patients
participated (PST conditions = 1,576, other therapy condi-
tions = 542, control conditions = 1,412). Participants were recrui-
ted through: (a) announcements in local newspapers and other
media (12 studies), (b) referrals from health services (eight
studies), (c) other recruitment strategies (such as screening at
general medical services; nine studies), and one study did not
report the recruitment strategy. In total, 14 studies were targeted
at adults, eight were targeted at elderly adults, two were targeted
at ethnic minorities, four were targeted at adults with a general
medical disorder, one at adult caregivers, and one was targeted at
women with postpartum depression. Brief PST was used in
15 studies, Extended PST was used in 10 studies, and Self-
Examination PST was used in five studies).
In three of the comparisons between PST and another therapy
condition, cognitive behavior therapy was used as the comparator,
two used behavioural activation therapy, one used case manage-
ment, three used non-directive supportive therapy, one used
referral, one used reminiscence, one used social skills training, and
one used stress management. Seven studies used a group
treatment format, 16 studies utilized individual treatment, five
used a guided self-help treatment format, and two studies used
another format. The number of treatment sessions ranged from
four to 12. For the control group, 12 studies used a waiting list,
seven studies used care-as-usual, five studies used antidepressant
medication, three studies used placebo, and one study used
another control group. 18 studies were conducted in North
America, 11 were conducted in Europe, and one was conducted in
Africa.
Selected characteristics of the 264 studies on psychotherapies
other than PST (with 342 comparisons between treatment and
control groups) are presented in Appendix B in Supplementary
material and the references for these studies are given in Appendix
C in Supplementary material.
3.3. Risk of bias
The risk of bias in most of the studies on PST was considerable. A
total of 14 of the 30 studies reported an adequate sequence
generation (47%). Thirteen studies reported allocation to condi-
tions by an independent (third) party (43%). Ten studies reported
[(Fig._1)TD$FIG]
Fig. 1. Flowchart for the inclusion of studies.
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report outcomes. In 16 studies intent-to-treat analyses (complete-
ness of follow-up data) were conducted (53%). Only seven studies
(23%) met all quality criteria. 12 studies (40%) met two or three of
the criteria and the 11 remaining studies met no or only one
criterion.
3.4. Effects of PST compared with control groups
We could compare the effect of PST with control groups in
27 comparisons. The overall effect size was g = 0.79 (95% CI: 0.57–
1.01), which corresponds with a NNT of 3.64. Heterogeneity was
very high (I2 = 84; 95% CI: 77–88). The results of these analyses are
summarized in Table 2. The effect sizes for each study are
presented in the forest plot in Fig.2.
In three studies ([22,23,42]; see Table 1), two types of therapies
that met our definition of PST were compared with the same
control group. Because these effect sizes were not independent of
each other, they may have artificially reduced heterogeneity and
influenced the effect sizes. We conducted two separate analyses toexamine this. In the first analysis we only included the largest
effect size from each study, and in the second only the smallest
effect size. As can be seen in Table 2, the effect sizes and levels of
heterogeneity were comparable to those in the main analyses.
When we limited the effect sizes to those based on the HAM-D and
the BDI (the most used instruments), we found that the effect sizes
were larger than those found in the overall analyses, especially for
the HAM-D. Levels of heterogeneity remained comparable.
We found strong indications for publication bias (Fig. 3). Duvall
and Tweedie’s trim and fill procedure suggested that 10 studies
were missing and after imputation of these studies the effect size
dropped from g = 0.79 to g = 0.39 (95% CI: 0.14–0.64). Egger’s test
of the intercept also pointed at considerable publication bias
(intercept: 3.32; 95% CI: 1.46–5.17; p < 0.001).
In order to generate the best estimate of the true effect size, we
selected the studies with low risk of bias (9 comparisons; g = 0.34;
95% CI: 0.22–0.46; NNT = 9.49; I2 = 32; 95% CI: 0–68), and adjusted
that for publication bias. The resulting effect size was g = 0.28; 95%
CI: 0.14–0.42; number of imputed studies: 2), which corresponds
with a NNT of 11.77.
Table 1
Selected characteristics of studies examining problem solving therapy for adult depression (N = 3.357).
Target group Recr Diagnosis Conditions N Type Format N sessions Country Risk of Biasa
Alexopoulos [46] Elderly Not reported MDD 1. PST 12 Ext ind 12 NrthAmer + +
2. SUP 13
Alexopoulos [47] Elderly Comm MDD 1. PST 110 Ext ind 12 NrthAmer + sr +
2. SUP 111
Alexopoulos [48] Elderly Other MDD 1. PST 84 Ext ind 12 NrthAmer ++ +
2. Case manag. 87
Arean [49] Elderly Comm MDD 1. PST 19 Ext grp 12 NrthAmer +
2. Reminiscence 28
3. WL 20
Barrett [50] Adults Clin Mood 1. PST 80 Brf ind 6 NrthAmer + + sr +
2. ADM 80
3. Placebo 81
Bowman [51] Adults Comm Cut-off 1. PST 10 SET gsh 4 NrthAmer 
2. CBT 10
3. WL 10
Chibanda [52] Women with PPD Clin MDD 1. PST 27 Brf grp 12 Africa +
2. ADM 22
Choi [42] Elderly Other Cut-off 1. PST – ftf 42 Brf ind 6 NrthAmer +
2. PST – tel 43
3. Other 36
Dowrick [53] Adults Other Mood 1. PST 98 Brf ind 6 EU + + sr +
2. CBT 80
3. CAU 139
Ebert [54] Adults Comm Cut-off 1. PST 75 SET gsh 5 EU + + sr +
2. WL 75
Gellis [55] Elderly Other subclinical 1. PST 30 Brf ind 6 NrthAmer + +
2. CAU 32
Hopko [56] Med. Dis. Clin MDD 1. PST 38 Brf ind 8 NrthAmer + sr +
2. BA 42
Kiosses [57] Elderly Comm MDD 1. PST 15 Ext ind 12 NrthAmer + +
2. SUP 15
Kleiboer [58] Adults Comm Cut-off 1. PST 106 SET gsh 5 EU + + sr +
2. WL 106
Lexis [59] Adults Other Cut-off 1. PST 69 Ext ind 10 EU + sr +
2. CAU 70
Lynch [60] Adults Clin subclinical 1. PST 11 Brf other 6 NrthAmer  sr
2. CAU 13
Lynch [61] Adults Clin Cut-off 1. PST 9 Brf other 6 NrthAmer +
2. Stress manag. 9
3. CAU 13
Malouff [62] Ethnical Minority Comm Cut-off 1. PST 15 Brf grp 4 NrthAmer  sr
2. CBT (RET) 14
3. WL 14
Mynors-Wallis [63] Adults Clin MDD 1. PST 29 Brf ind 6 EU + +
2. ADM 27
3. Placebo 26
Mynors-Wallis [64] Adults Clin MDD 1. PST – gp 39 Brf ind 6 EU + + +
2. PST – nurse 41
3. ADM 36
4. PST + ADM 35
Nezu [22] Adults Comm Mood 1. PST – full 11 Ext grp 8 NrthAmer  sr
2. PST – pf 9
3. WL 6
Nezu [23] Adults Comm Mood 1. PST – full 14 Ext grp 8 NrthAmer  sr
2. PST – abbr 14
3. WL 11
Nollett [65] Med. Dis. Other Cut-off 1. PST 22 Brf ind 6 EU + + sr
2. Referral 26
3. WL 27
Schmitt [66] Adults Comm Mood 1. PST 14 Ext grp 12 NrthAmer 
2. SST 10
3. WL 6
Strong [67] Med. Dis. Other MDD 1. PST 97 Ext ind 10 EU + + sr +
2. CAU 99
Teri [68] Med. Dis. Other Mood 1. PST 19 Brf ind 9 NrthAmer +
2. BA 23
3. WL 20
Unlu [69] Ethnical Minority Comm Cut-off 1. PST 49 SET Gsh 5 EU + sr +
2. WL 47
Vazquez [70] Nonprofessional caregivers Other Cut-off 1. PST 89 Brf Grp 5 EU + sr +
2. CAU 84
Warmerdam [71] Adults Comm Cut-off 1. PST 88 SET Gsh 5 EU + + sr +
2. CBT 88
3. WL 87
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Table 1 (Continued )
Target group Recr Diagnosis Conditions N Type Format N sessions Country Risk of Biasa
Williams [72] Elderly Clin Mood 1. PST 113 Brf ind 6 NrthAmer + + + +
2. ADM 106
3. Placebo 119
Note: Abbr.: Abbreviated; ADM: Anti-depressant Medication; BA: Behavioral Activation; Brf: Brief; CAU: Care as Usual; CBT: Cognitive Behavioral Therapy; Clin: participants
recruited in a clinical setting; Comm: participants recruited in a community setting; CT: Cognitive Therapy; Diagn: Diagnosis; EU: Europe; Ext: Extended; ftf: Face-to-face;
GP: General Practitioner; Grp: group format; Gsh: guided self-help format; Ind: individual format; MDD: Major Depressive Disorder; Med. Dis.: Medical Disorder; Nsess:
Number of sessions; Pf: Problem-Focused; PPD; Post-Partum Depression; Recr: Recruitment; RoB: Risk of Bias; SET: Self-Examination Therapy; SST: Social Skills Training;
SUP: Nondirective Supportive Therapy; tel: Telephone; WL: Waitlist.
a In this column a positive (+) or negative () sign is given for four quality criteria of the study, respectively: allocation sequence; concealment of allocation to conditions;
blinding of assessors; and intention-to-treat analyses. Sr in the third criterion indicates that only self-report measures (and no assessor) were used.
[(Fig._2)TD$FIG]
Fig. 2. Forrest plot of effect sizes from randomized controlled trials on problem-solving therapy for adult depression.
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versus control groups at the longer term, one (with two
comparisons) at 6 months and two at 12 months follow-up.
However, only one of these studies had low risk of bias. The pooled
effect size was g = 0.35 (95% CI: 0.14–0.56; I2 = 18; 95% CI: 0–73;
NNT = 9.19).
3.5. Subgroup and meta-regression analyses
In order to examine possible sources of heterogeneity, we
conducted a series of subgroup analyses (Table 2). We found
several significant differences between subgroups. Studies in
which patients were recruited from the community resulted in
significantly higher effect sizes than studies among patients from
clinical samples and patients that were recruited in other ways
(p = 0.001). Group treatments resulted in higher effect sizes than
individual, and guided self-help treatments (p = 0.002). Studies
conducted in North America had considerably higher effect sizes
than studies from Europe (p = 0.03). Studies with a waiting list
control condition had higher effect sizes than studies with a care-as-usual or another control group (p = 0.004), and studies with
low risk of bias had lower effect sizes than studies with high risk
of bias (p < 0.001). We found no indication that target group,
diagnosis or type of PST were significantly related to the effect
size.
Because there were several studies with very high effect sizes,
which may have distorted these subgroup analyses, we repeated
the analyses while excluding studies with effect sizes larger than
g = 1.5. We found that the results were overall very comparable,
and all significant subgroup analyses remained significant, except
for the difference between effect sizes in North-American and
Europe.
We also conducted a multivariate regression analysis (with the
effect size as dependent variable) in which all variables of the
subgroup analyses were simultaneously entered as predictors. All
variables were entered as categorical variables, except risk of bias
that was entered as a continuous variable. We also added the
number of treatment sessions as continuous variable. In these
analyses none of the predictors remained significantly associated
with the effect size.
[(Fig._3)TD$FIG]
Fig. 3. Funnel plot of standard error by Hedges’ g.
P. Cuijpers et al. / European Psychiatry 48 (2018) 27–37 33In order to avoid overfit of the meta-regression model, we
repeated this meta-regression analysis, with a (manual) stepwise
backward elimination of the least significant predictor until only
significant predictors remained in the model. This analysis resulted
in only one significant predictor, namely risk of bias (coefficient:
0.26, SE: 0.09, p = 0.008). Higher risk of bias resulted in larger
effect sizes.
3.6. Direct comparisons of PST versus other treatments
We could compare PST with another type of psychotherapy in
12 comparisons. We found a significant effect size indicating
superior effects of PST compared with other therapies at post-test,
with g = 0.18 (95% CI: 0.01–0.35; NNT = 19.00). Heterogeneity was
low (I2 = 27; 95% CI: 0–63).
Because the number of studies was so small we only conducted
two subgroup analyses. In the first subgroup analyses we
examined whether the effects in studies with high risk of bias
were different from those with low risk of bias. The effect sizes in
the two groups of studies did not differ significantly, possibly
because of low statistical power related to the small number of
studies with low risk of bias. Both subgroups resulted in a small,
non-significant differential effect size.
In the second subgroup analysis we compared studies with
researcher allegiance to those without. The difference between the
subgroups was not significant, but the five studies without
allegiance did not result in a significant difference between PST
and other therapies.
We could compare PST with antidepressant medication in
6 comparisons. We found no significant difference between the
two (g = 0.09; 95% CI:0.13–0.30). Because of the small number of
studies we did not conduct further analyses.
3.7. Controlled trials on PST versus controlled trials on other
psychotherapies
We compared the 27 comparisons between PST and a control
condition to the 342 comparisons of other psychotherapies versus
control conditions, and found no significant difference (other
therapies: g = 0.69; 95% CI: 0.64–0.74; I2 = 75; 95% CI: 72–78;
NNT = 4.25; p for difference with PST: 0.50).Then we conducted a multivariate meta-regression analysis in
which we included type of therapy as well as other characteristics
of the participants, the therapies and the studies as predictor in the
model. The results are presented in Table 3 (full model). As can be
seen, there was no indication that the effect size found for PST
differed from the effect sizes of other therapies after adjustment
for the other characteristics of the participants, therapies and
studies.
We conducted again another multivariate metaregression
analysis with a (manual) stepwise backward elimination of the
least significant predictor until only significant predictors remai-
ned in the model (except type of therapy that was not removed
from the model, because this was the variable of interest). The
same variables that were significant in the full model were also
significant in the parsimonious model, and there was no indication
that PST differed significantly from the other types of therapy.
4. Discussion
In this updated meta-analysis of PST for adult depression we
found an overall large effect of PST compared to control conditions.
However, a better estimate of the true effect size, based on studies
with low risk of bias and after adjustment for publication bias
pointed at a small effect of PST. This is in line with research on
other treatments of depression, such as cognitive behavior therapy
[1] and interpersonal psychotherapy [4], where overall large
effects are found but much smaller ones in high-quality studies
and after adjustment for publication bias [43,44].
Direct comparisons of PST with other types of psychotherapy
showed a small significant effect in favor of PST. However, in a
considerable number of studies (more than half of the 11 trials) we
found indications for researcher allegiance in favor of PST. These
findings should therefore be considered with caution. A compari-
son of trials on PST versus control groups and the large number of
trials on other therapies versus control groups, also indicated no
significant difference between PST and other therapies. Further-
more, no differential effect of any of the other types of therapy was
found, suggesting that all therapies are equally or about equally
effective. This is also in line with several previous large meta-
analyses showing no or only small differences between therapies
for depression [11,28].
Table 2
Effects of problem-solving therapy compared with control groups and other treatments: Hedges’ g.a
Ncomp g 95% CI I
2 95% CI pb NNT
PST versus control
All studies 27 0.79 0.57–1.01 84 77–88 3.64
One comparison per study (highest) 24 0.77 0.54–1.01 85 79–89 3.74
One comparison per study (lowest) 24 0.70 0.48–0.91 82 74–87 4.18
Outliers excludedc 19 0.61 0.46–0.77 42 0–65 4.89
Only HAMD 11 1.36 0.89–1.83 80 63–88 2.02
Only BDI 12 0.99 0.58–1.40 75 52–85 2.82
Only low risk of bias 9 0.34 0.22–0.46 32 0–68 9.49
Subgroup analyses
Target group Adults in general 15 0.70 0.44–0.96 75 56–84 0.79 4.18
Older adults 6 0.91 0.30–1.51 91 84–94 3.10
Other 6 0.81 0.29–1.33 86 69–92 3.53
Diagnosis Diagnosed mood dis 13 0.76 0.45–1.07 81 67–87 0.87 3.80
Cut-off 14 0.80 0.49–1.11 85 75–89 3.58
Recruitment Community 12 1.08 0.73–1.43 75 52–85 0.001 2.56
Clinical 5 0.27 0.00–0.55 42 0–77 12.25
Other 10 0.74 0.35–1.13 90 85–93 3.92
Type of PST Extended 9 1.06 0.58–1.54 83 68–90 0.14 2.62
Brief 13 0.74 0.37–1.11 89 83–92 3.92
Self-examination 5 0.55 0.35–0.75 26 0–73 5.51
Format Individual 11 0.51 0.23–0.79 84 72–89 0.002 6.01
Group 8 1.56 1.14–1.97 52 0–77 1.78
GSH/other 8 0.55 0.39–0.72 13 0–62 5.51
Country North America 17 1.04 0.66–1.42 86 78–90 0.03 2.67
Europe 9 0.54 0.29–0.79 81 64–88 5.63
Control group Waiting list 14 0.98 0.67–1.30 74 52–83 0.004 2.85
Care-as-usual 7 0.86 0.29–1.42 93 88–95 3.30
Other 6 0.34 0.12–0.56 50 0–78 9.49
Risk of bias 0–2 14 1.30 0.87–1.72 77 60–85 0.000 2.11
3–4 13 0.44 0.23–0.65 80 65–87 7.11
PST versus control at follow-up
All studies 4 0.35 0.14–0.56 18 0–73 9.19
PST vs Other therapies
All studies 12 0.18 0.01–0.35 27 0–63 19.00
Subgroup analyses
Risk of bias 0-2 (high RoB) 9 0.23 -0.04–0.49 21 0–63 0.66 14.59
3-4 (low RoB) 3 0.14 -0.11–0.40 59 0–86 24.82
Allegiance Yes 6 0.31 0.02–0.61 34 0–73 0.22 10.52
No 6 0.07 -0.11–0.25 0 0–61 51.09
PST vs ADM
All studies 6 0.09 -0.13–0.30 40 0–75 39.40
Abbreviations: ADM: Anti-Depressant Medication; BDI: Beck Depression Inventory; CI: Confidence interval; GSH: Guided Self-Help; HAMD: Hamilton Rating Scale for
Depression; Ncomp: number of comparisons; NNT: Numbers-needed-to-treat; PST: Problem Solving Therapy; RoB: Risk of Bias.
a according to the random effects model.
b The p-values in this column indicate whether the difference between the effect sizes in the subgroups is significant.
c Outliers were: Alexopoulos, 2016; Barret, 2001; Dowrick, 2000; Gellis, 2010; one of the comparisons from Nezu et al., 1986; one of the comparisons from Nezu et al., 1989;
Vazquez, 2013; Williams et al., 2000.
P. Cuijpers et al. / European Psychiatry 48 (2018) 27–3734We also found that the set of high-quality studies resulted in a low
level of heterogeneity, although there was still some uncertainty
around this low level. But overall this set of high-quality studies was
consistent in pointing a small effect size, with no large deviations from
that. Most of the heterogeneity was introduced by the studies with
low or uncertain quality, which resulted in levels of heterogeneity of
up to 80%. This in line with our previous meta-analysis on problem-
solving [25], where we also found a high level of heterogeneity, but
could not find explanations for that in subgroup analyses. The number
of high-quality studies was too small to examine whether their
characteristics differed from studies of lower-qualities.
We found no significant difference between the three types of
PST that we examined. However, the extended PST with 10 or more
sessions did result in a considerably larger effect size, although that
difference was not significant. The difference between extended
and the other two types of PST may not have reached significance
because of low statistical power. We had certainly too little power
to examine a possible difference between the three types in high-quality studies. So it remains uncertain whether there is difference
between these types of PST.
In the draft NICE treatment guidelines for depression [45] PST is
not considered as a separate type of treatment and is included in
the broader ‘‘family’’ of cognitive behavioral therapies, together
with rational emotive behavior therapy and third-wave therapies.
Although we do think that PST can be seen as a member of a
broader ‘‘family’’ of cognitive behavioral therapies, we think this
can be easily disputed. Cognitive restructuring is typically
considered to be the core of cognitive behavioral therapies or at
least one of the core elements. In PST, however, problem solving
skills are the core of the treatment, and cognitive restructuring is
not included in most of the PST manuals. We think therefore, that
the NICE guidelines have missed an opportunity to examine the
contribution of PST to treatments of depression. Because PST is
included in cognitive behavioral therapy there is a risk that
clinicians will be inclined not to use it anymore, while it still is one
of the best examined therapies for depression.
Table 3
Standardized regression coefficients of characteristics of studies on problem solving therapy and other psychological treatments of adult depression: Multivariate
metaregression analyses.
Full model Parsimonious model
Coeff. SE p
Recruitment Community Ref.
Clinical samples 0.14 0.09 0.13
Other 0.01 0.08 0.92
Diagnosis vs cut-off 0.11 0.08 0.92
Type PST Ref. Ref.
BAT 0.07 0.18 0.70 0.08 0.18 0.65
Dynamic 0.24 0.21 0.26 0.23 0.20 0.24
CBT 0.10 0.12 0.42 0.09 0.12 0.44
IPT 0.21 0.16 0.20 0.19 0.16 0.25
Supportive 0.11 0.18 0.54 0.07 0.17 0.68
Other 0.12 0.14 0.40 0.14 0.13 0.30
Third wave 0.01 0.17 0.96 0.00 0.17 0.98
Format Individual Ref.
Group 0.03 0.08 0.72
Guided self-help 0.04 0.10 0.68
Other 0.20 0.14 0.15
Number of sessions (continuous) 0.00 0.01 0.81
Risk of bias (continuous) 0.12 0.03 <0.001 0.11 0.02 <0.001
Control group Waiting list Ref. Ref.
Care as usual 0.17 0.09 0.05 0.19 0.07 0.01
Other 0.30 0.09 <0.001 0.30 0.09 <0.001
Western vs non-Western country 0.43 0.10 <0.001 0.43 0.09 <0.001
Intercept 1.30 0.15 <0.001 1.15 0.13 <0.001
R2 analog 0.24 0.24
Abbreviations: BAT: Behavioral Activation Therapy; CBT: Cognitive Behavior Therapy; Coeff: Regression Coefficient; HAMD: Hamilton Rating Scale for Depression; IPT:
Interpersonal Psychotherapy; p: this p-value indicates whether the regression coefficient of the subgroup differs significantly from the reference group; PST: Problem Solving
Therapy; Ref: Reference group; SE: Standard Error.
P. Cuijpers et al. / European Psychiatry 48 (2018) 27–37 35This study had several limitations. The most important one is
that we could include only a relatively small sample of studies, and
less than 10 studies of high-quality. This resulted in low power to
examine the effects and moderators of the effects of PST. Another
limitation is that hardly any study examined the long-term effects
of PST. We also found considerable indications for publication bias.
And in the studies comparing PST with other psychotherapies we
found researcher allegiance in more than half of the studies,
affecting the value of these studies.
Despite these limitations we can conclude that PST is probably
an effective treatment of depression, with effect sizes that are
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